EXHIBIT
      31.1




**CERTIFICATION
      OF PRINCIPAL EXECUTIVE OFFICER**


**PURSUANT
      TO RULES 13a-14 AND 15d-14 OF THE**


**SECURITIES
      EXCHANGE ACT OF 1934**






I,
      Wolfgang
      Barnikol, certify that:





1. I
      have
      reviewed this quarterly report on Form 10-QSB of Sangui BioTech International,
      Inc.





2.           Based
        on my knowledge, this report does not contain any untrue statement of a material
        fact or omit to state a material fact necessary to make the statements made,
        in
        light of the circumstances under which such statements were made, not misleading
        with respect to the period covered by this report;
 
 3.           Based
        on my knowledge, the financial statements, and other financial information
        included in this report, fairly present in all material respects the financial
        condition, results of operations and cash flows of the registrant as of,
        and
        for, the periods presented in this report;
 
 4.           I
        am responsible for establishing and maintaining disclosure controls and
        procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for
        the
        small business issuer and have:
 
 (a)         Designed
        such disclosure
        controls and procedures, or caused such disclosure controls and procedures
        to be
        designed under my supervision, to ensure that material information relating
        to
        the small business issuer, including its consolidated subsidiary, is made
        known
        to us by others within those entities, particularly during the period in
        which
        this report is being prepared;
 
 (b)         Evaluated
        the effectiveness of the small business issuer’s disclosure controls and
        procedures and presented in this report our conclusions about the effectiveness
        of the disclosure controls and procedures, as of the end of the period covered
        by this report based on such evaluation; and
 
 (c)         Disclosed
        in this report any change in the small business issuer’s internal control over
        financial reporting that occurred during the small business issuer’s most recent
        fiscal quarter that has materially affected, or is reasonably likely to
        materially affect, the small business issuer’s internal control over financial
        reporting; and
  5.           I
        have disclosed, based on my most recent evaluation of internal control over
        financial reporting, to the small business issuer’s auditors and the audit
        committee of the small business issuer’s board of directors (or persons
        performing the equivalent functions):
  (a)         All
        significant deficiencies and material weaknesses in the design or operation
        of
        internal control over financial reporting which are reasonably likely to
        adversely affect the small business issuer’s ability to record, process,
        summarize and report financial information; and
  (b)         Any
        fraud, whether or not material, that involves management or other employees
        who
        have a significant role in the small business issuer’s internal control over
        financial reporting.




Date:
          November 30,
          2007                             /s/  Wolfgang
          Barnikol
 By:
        Wolfgang Barnikol
 Chief
        Executive Officer and Chief Financial Officer